authors
- Michael Nanna, MD, MHS
- Knop, Filip K
- Smolderen, Kim G
- Mena-Hurtado, Carlos
- Divino, Victoria
- Zhao, Zhenxiang
- Chen, Yan
- Boland, Joanna
- Song, Jinlin
- Traina, Andrea
- Ozer, Kerem
Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real-World: Results From the SCORE-Clinical ASCVD Study.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- March 26, 2026
published in
- Diabetes, obesity & metabolism Journal